Next Article in Journal
In-Depth In Silico Search for Cuttlefish (Sepia officinalis) Antimicrobial Peptides Following Bacterial Challenge of Haemocytes
Next Article in Special Issue
Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders
Previous Article in Journal
The Microbial Community Associated with Rhizostoma pulmo: Ecological Significance and Potential Consequences for Marine Organisms and Human Health
Previous Article in Special Issue
Epicortical Brevetoxin Treatment Promotes Neural Repair and Functional Recovery after Ischemic Stroke
Open AccessArticle

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model

by 1,2,3, 4, 1,2,3, 1,2 and 1,2,*
1
Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China
2
Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266071, China
3
University of the Chinese Academy of Sciences, Beijing 100049, China
4
College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2020, 18(9), 438; https://doi.org/10.3390/md18090438
Received: 9 June 2020 / Revised: 14 August 2020 / Accepted: 18 August 2020 / Published: 23 August 2020
(This article belongs to the Special Issue Marine Natural Products against Brain Diseases and Injuries)
Parkinson’s disease (PD), characterized by dopaminergic neuron degeneration in the substantia nigra and dopamine depletion in the striatum, affects up to 1% of the global population over 50 years of age. Our previous study found that a heteropolysaccharide from Saccharina japonica exhibits neuroprotective effects through antioxidative stress. In view of its high molecular weight and complex structure, we degraded the polysaccharide and subsequently obtained four oligosaccharides. In this study, we aimed to further detect the neuroprotective mechanism of the oligosaccharides. We applied MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to induce PD, and glucuronomannan oligosaccharides (GMn) was subsequently administered. Results showed that GMn ameliorated behavioral deficits in Parkinsonism mice. Furthermore, we observed that glucuronomannan oligosaccharides contributed to down-regulating the apoptotic signaling pathway through enhancing the expression of tyrosine hydroxylase (TH) in dopaminergic neurons. These results suggest that glucuronomannan oligosaccharides protect dopaminergic neurons from apoptosis in PD mice. View Full-Text
Keywords: glucuronomannan oligosaccharides; behavioral deficits; Parkinson’ disease; apoptosis glucuronomannan oligosaccharides; behavioral deficits; Parkinson’ disease; apoptosis
Show Figures

Figure 1

MDPI and ACS Style

Liu, Y.; Jin, W.; Deng, Z.; Wang, J.; Zhang, Q. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model. Mar. Drugs 2020, 18, 438. https://doi.org/10.3390/md18090438

AMA Style

Liu Y, Jin W, Deng Z, Wang J, Zhang Q. Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model. Marine Drugs. 2020; 18(9):438. https://doi.org/10.3390/md18090438

Chicago/Turabian Style

Liu, Yingjuan; Jin, Weihua; Deng, Zhenzhen; Wang, Jing; Zhang, Quanbin. 2020. "Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson’s Model" Mar. Drugs 18, no. 9: 438. https://doi.org/10.3390/md18090438

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop